Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 155 (4) , 1205-1217
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitisGut, 2013
- Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cellsNature Medicine, 2013
- CCR6 as a mediator of immunity in the lung and gutExperimental Cell Research, 2011
- Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relativesGut, 2011
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsProceedings of the National Academy of Sciences, 2008
- Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functionsBlood, 2004
- CD4+ CD8+ double positive (DP) T cells in health and diseaseAutoimmunity Reviews, 2004
- Oligonucleotide Probes That Detect Quantitatively Significant Groups of Butyrate-Producing Bacteria in Human FecesApplied and Environmental Microbiology, 2003
- CD4+CD8dim T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigensEuropean Journal of Immunology, 2001